Health In Tech, Inc. (HIT) stock
HITNasdaqInsurance Agents, Brokers & ServiceFiscal year ends December 31
$0.40−0.14 (-26.12%)
Close on Nov 13, 2026Market cap $25.92MP/E –Yield –
Health In Tech r&d expenses
Research and development expenses are spending on new products and technology.
Health In Tech's R&D Expenses for the twelve months ending Sep 30, 2026 was $2.95M, up 48.1% year over year. For fiscal 2025 it was $1.57M, down 44.2% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.57M | -44.2% |
| FY2024 | Dec 31, 2024 | $2.81M | +40.4% |
| FY2023 | Dec 31, 2023 | $2.00M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $938.56K | +298.0% |
| Q2 FY2026 | Jun 30, 2026 | $875.81K | +50.3% |
| Q1 FY2026 | Mar 31, 2026 | $920.40K | +71.2% |
| Q4 FY2025 | Dec 31, 2025 | $213.11K | -66.4% |
| Q3 FY2025 | Sep 30, 2025 | $235.82K | -67.2% |
| Q2 FY2025 | Jun 30, 2025 | $582.61K | -17.0% |
| Q1 FY2025 | Mar 31, 2025 | $537.72K | -29.3% |
| Q4 FY2024 | Dec 31, 2024 | $633.65K | – |
| Q3 FY2024 | Sep 30, 2024 | $718.42K | – |
| Q2 FY2024 | Jun 30, 2024 | $701.63K | – |
| Q1 FY2024 | Mar 31, 2024 | $760.20K | – |
See a number that looks wrong?